Prevention and treatment of amyloidogenic disease

Details for Australian Patent Application No. 2005202644 (hide)

Owner Elan Pharma International Limited

Inventors Schenk, Dale B.

Agent Spruson & Ferguson

Pub. Number AU-B-2005202644

Parent 53163

Filing date 17 June 2005

Wipo publication date 14 July 2005

Acceptance publication date 5 March 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

30 June 2005 Complete Application Filed

14 July 2005 Application Open to Public Inspection

  Published as AU-B-2005202644

5 March 2009 Application Accepted

  Published as AU-B-2005202644

9 July 2009 Standard Patent Sealed

16 December 2010 Assignment Registered

  Elan Pharma International Limited The patent has been assigned to Jassen Alzheimer Immunotherapy

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202645-Power Steering System

2005202643-Tub construction for dishwasher